StockData

Cognyte Software vs Cellebrite DI

CGNT and CLBT side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CGNT and CLBT compare

Cellebrite DI grew revenue faster over the last twelve months (18.6% versus 14.1% for Cognyte Software).

Cellebrite DI keeps more of each dollar of sales as profit, with a net margin of 16.5% compared with −0.16% at Cognyte Software.

Cellebrite DI scores higher on the StockData Score (13 against 10 for Cognyte Software), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCGNTCLBT
Size and price
Share price$8.24$11.53
Change, 1 year−4.1%−27.8%
Change, 5 years−61.5%24.5%
Beta (5Y)1.260.91
Employees8311,005
StockData Score
Total score1013 (better)
Valuation score00
Growth score22
Performance score36 (better)
Health score55
Dividend score00
Growth
Revenue growth (TTM)14.1%18.6% (better)
Revenue growth, 5Y average−2.0%19.5% (better)
Profitability
Gross margin72.4%84.2% (better)
Operating margin3.3%14.0% (better)
Net margin−0.16%16.5% (better)
FCF margin7.5%33.7% (better)
Return on equity−0.32%16.6% (better)
Return on invested capital7.6%35.4% (better)
Financial health
Debt / equity0.000.00
Interest coverage68.4×–
Current ratio1.331.62 (better)
Piotroski F-score7 (better)5
Ownership
Held by institutions–50.3%
Held by insiders8.0%7.1%
Insider net buying, 12 months–−$5.4M
Superinvestors holding–1
Short interest, % of float0.74%2.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.